Posts in High-Alert Medications

In our August 10, 2006 newsletter, we highlighted the well-known, caustic effects of promethazine and suggested ways to reduce the risk of serious tissue injuries and amputations from inadvertent arterial injection or IV extravasation. This topic evoked considerable response from the media and...
In our January 11, 2007 newsletter, we announced our 2007 New Year's resolution to highlight for our readers key information about selected high-alert medications and how to reduce patient harm when prescribing, dispensing, and administering these drugs. We began this yearlong effort with a feature...
ISMP leverages multidisciplinary expertise across hundreds of similar healthcare facilities to provide customized guidance on effective use of medication safety data.
The ISMP Medication Safety Self Assessment® for Oncology is designed to heighten awareness of distinguishing systems and practices related to the safe use of chemotherapy, biotherapy, and treatment-related drugs.
Signals for dabigatran (PRADAXA) and dalfampridine (AMPYRA) • Updates on our reporting on the smoking cessation drug varenicline (CHANTIX) • Annual ranking of the drugs most frequently associated with reports of serious injury